Adaptive Biotechnologies (ADPT) Tops Q3 EPS by 2c; Reports Cash and Cash Equivalents of $632.4M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $27.57 +3.22%
Financial Fact:
Net income (loss) (in Dollars per share): -5.69
Today's EPS Names:
KELYA, ROX, KEEL, More
Financial Fact:
Net income (loss) (in Dollars per share): -5.69
Today's EPS Names:
KELYA, ROX, KEEL, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q3 EPS of ($0.40), $0.02 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $39.5 million versus the consensus estimate of $36.64 million.
GUIDANCE:
Adaptive Biotechnologies sees FY2021 revenue of $148-155 million, versus the consensus of $152 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Becton Dickinson (BDX) Tops Q4 EPS by 8c; Offers Guidance
- Enovis Corporation (ENOV) Tops Q3 EPS by 11c ; Offers Guidance
- ScanSource (SCSC) Misses Q1 EPS by 25c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
